Nitroglycerin (Glyceryl Trinitrate)

Glyceryl Trinitrate releases nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting rise in cyclic GMP causes relaxation of veins and arteries, decreasing preload and afterload and improving oxygen delivery to the heart.

The specific dose and infusion rate of Nitroglycerin are determined by the prescribing clinician based on the patient’s condition, response, and monitoring parameters. Dosing is individualized and should follow local clinical guidelines.

Safety data for Nitroglycerin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Nitroglycerin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitroglycerin provides rapid, short‑acting vasodilation, making it ideal for emergency relief of angina. Other anti‑anginals such as beta‑blockers or calcium‑channel blockers have longer‑acting effects and different mechanisms, so the choice depends on the clinical scenario and patient profile.

Nitroglycerin IV solution should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the product, and ensure it remains within the recommended temperature range until use.

Nitroglycerin is administered intravenously, typically as a continuous infusion or intermittent bolus under strict clinical monitoring. The infusion set is primed, and the rate is adjusted according to blood pressure and symptom response.

The most serious risks include severe hypotension leading to syncope, myocardial infarction in vulnerable patients, life‑threatening arrhythmias, and rare cases of methemoglobinemia. Immediate medical attention is required if any of these events occur.

Nitroglycerin is contraindicated in patients with known hypersensitivity to nitrates, those who have taken phosphodiesterase‑5 inhibitors within the past 24‑48 hours, and individuals with severe hypotension or uncontrolled shock.